Literature DB >> 15942304

Molecular pathology of non-small-cell lung cancer.

R H J Breuer1, P E Postmus, E F Smit.   

Abstract

The molecular basis of lung carcinogenesis must be understood more fully and exploited to enhance survival rates of patients suffering from lung cancer. In this review we will discuss the major molecular alterations that occur in lung cancer. Emphasis is placed on alterations that occur early during carcinogenesis since they might be relevant for future screening programs. Finally we will shortly review new approaches that are used to study the molecular pathology of lung cancer and how they can be applied in a clinical setting. Copyright 2005 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15942304     DOI: 10.1159/000085376

Source DB:  PubMed          Journal:  Respiration        ISSN: 0025-7931            Impact factor:   3.580


  17 in total

1.  Association of progressive structural changes in the bronchial epithelium with subepithelial fibrous remodeling: a potential role for hypoxia.

Authors:  Vasiliy V Polosukhin; William E Lawson; Aaron P Milstone; Svetlana M Egunova; Andrey G Kulipanov; Sergey G Tchuvakin; Pierre P Massion; Timothy S Blackwell
Journal:  Virchows Arch       Date:  2007-08-03       Impact factor: 4.064

2.  Expression of peroxisome proliferator activated receptor-gamma (PPAR-γ) in human non-small cell lung carcinoma: correlation with clinicopathological parameters, proliferation and apoptosis related molecules and patients' survival.

Authors:  Costantinos Giaginis; Ekaterini Politi; Paraskevi Alexandrou; John Sfiniadakis; Gregory Kouraklis; Stamatios Theocharis
Journal:  Pathol Oncol Res       Date:  2012-03-18       Impact factor: 3.201

Review 3.  Molecular biology of lung cancer: clinical implications.

Authors:  Jill E Larsen; John D Minna
Journal:  Clin Chest Med       Date:  2011-10-07       Impact factor: 2.878

Review 4.  Targeted therapies for lung cancer: clinical experience and novel agents.

Authors:  Jill E Larsen; Tina Cascone; David E Gerber; John V Heymach; John D Minna
Journal:  Cancer J       Date:  2011 Nov-Dec       Impact factor: 3.360

5.  Oncogenic role of the E3 ubiquitin ligase NEDD4-1, a PTEN negative regulator, in non-small-cell lung carcinomas.

Authors:  Nicola Amodio; Marianna Scrima; Lucia Palaia; Ali Naeem Salman; Alfina Quintiero; Renato Franco; Gerardo Botti; Pino Pirozzi; Gaetano Rocco; Nicla De Rosa; Giuseppe Viglietto
Journal:  Am J Pathol       Date:  2010-10-01       Impact factor: 4.307

Review 6.  Somatic mutations of the epidermal growth factor receptor and non-small-cell lung cancer.

Authors:  Xiaozhu Zhang; Alex Chang
Journal:  J Med Genet       Date:  2006-12-08       Impact factor: 6.318

7.  Pathway crosstalk analysis of microarray gene expression profile in human hepatocellular carcinoma.

Authors:  Xiaodong Zhou; Ruiguo Zheng; Huifang Zhang; Tianlin He
Journal:  Pathol Oncol Res       Date:  2014-12-06       Impact factor: 3.201

8.  ATM sequence variants associate with susceptibility to non-small cell lung cancer.

Authors:  Hushan Yang; Margaret R Spitz; David J Stewart; Charles Lu; Ivan P Gorlov; Xifeng Wu
Journal:  Int J Cancer       Date:  2007-11-15       Impact factor: 7.396

9.  Correlation of transcription of MALAT-1, a novel noncoding RNA, with deregulated expression of tumor suppressor p53 in small DNA tumor virus models.

Authors:  Liesl K Jeffers; Kaiwen Duan; Lesley G Ellies; William T Seaman; Raquel A Burger-Calderon; Luda B Diatchenko; Jennifer Webster-Cyriaque
Journal:  J Cancer Ther       Date:  2013-05

10.  Screening feature genes of lung carcinoma with DNA microarray analysis.

Authors:  Liangdong Chen; Deqiang Zhuo; Jiakuan Chen; Hongyin Yuan
Journal:  Int J Clin Exp Med       Date:  2015-08-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.